Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc Stock

18.14P/E
€3.38BMarket capitalisation
US$1.73Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Catalyst Pharmaceuticals Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Catalyst Pharmaceuticals Inc stock.

Market capitalisation
€3.38B
P/E
18.14
P/B
3.79
P/S
6.69
P/CF
19.14
Issued shares 122M Units

Return

Here you can see the performance of the Catalyst Pharmaceuticals Inc stock.

PeriodPerfor­mance
1 Week0.00 %
1 Month+1.48 %
3 Months+27.91 %
6 Months+43.75 %
1 Year+49.62 %
YTD+36.68 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Catalyst Pharmaceuticals Inc share.

DateRatio
No data available.

Which ETF contains the Catalyst Pharmaceuticals Inc stock?

The Catalyst Pharmaceuticals Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Catalyst Pharmaceuticals Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Catalyst Pharmaceuticals Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.